Skip to main content

Stem Cells Show Reversal of Disability in Multiple Sclerosis

  • Synopsis: Published: 2016-04-15 (Revised/Updated 2016-05-07) - Stem cell treatment improves established disability in patients with progressive MS and shows there is hope future treatment is possible. For further information pertaining to this article contact: Tisch MS Research Center of New York at tischms.org.

Main Document

Quote: "This is the first treatment that improves established disability in patients with progressive MS and shows us there is hope that a future treatment is possible, stated Dr. Saud A. Sadiq"

Dr. Saud A. Sadiq, Director and Chief Research Scientist at the Tisch MS Research Center of New York (Tisch MSRCNY) will be presenting on Tuesday, April 19, 2016, the extraordinary results from his FDA-approved stem cell clinical trial for MS at the American Academy of Neurology's 68th Annual Meeting in Vancouver, BC, Canada. Dr. Sadiq will deliver the highly anticipated news during a session titled "Remyelination and Repair in Multiple Sclerosis (MS) Data Blitz Presentations."

The presentation reveals data from the Phase I trial showing that the novel stem cell treatment was safe and well-tolerated with no serious adverse events reported.

What's more, the cutting-edge protocol of this trial created at Tisch MSRCNY allowed for the delivery of brain-like neural cells within 30 minutes of harvesting, a technique not seen anywhere else in the world.

"Repair and regeneration is possible. We have a patient who no longer needs her cane, one who has transitioned from a motorized scooter to taking steps with a walker and another who has discontinued their bladder medication as those symptoms have dramatically improved. This is the first treatment that improves established disability in patients with progressive MS and shows us there is hope that a future treatment is possible," stated Dr. Saud A. Sadiq.

Due to these unprecedented results, the FDA has already advised Tisch MSRCNY to begin preparations for Phase II of this important trial to establish efficacy of stem cells as a reparative therapy. This is expected to commence at the end of 2016, once funding is secured.

The mission of the Tisch Multiple Sclerosis Research Center of New York is to conduct groundbreaking medical research to ensure unparalleled care and positive outcomes for MS patients. Its integrated relationship with the International MS Management Practice (IMSMP) accelerates the pace at which research discoveries translate from lab bench to bedside.

The Center aims to identify the cause of MS, understand disease mechanisms, optimize therapies, and repair the damage caused by MS while offering patients access to the best and most advanced treatments possible.



Related Information:

  1. Stem Cells Offer Hope for MS Treatment - BioMed Central
  2. Bone Marrow Stem Cells in MS Show Promise - The Multiple Sclerosis and Stem Cell Research Group
  3. A Step Closer to Cell Therapy for MS Patients - New York Stem Cell Foundation


Information from our Regenerative Medicine: Research & News section - (Full List).

Comments: We apologize but until we find a new secure & accessible comments plugin this area is not available.


     What will I receive?

Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.


Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.


List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.


Blood Pressure Chart - What should your blood pressure be. Also see information on blood group types and compatibility.


  1. CSD Learns Awarded $75,000 Grant from Wells Fargo
  2. 2016 FBI Hate Crime Statistics
  3. People Who Experience Dry Eye Soon to Have Drug-Free Solution
  4. FDA Warns About Illegal Use of Injectable Silicone for Body Contouring and Associated Health Risks




Citation